August 19, 2019

The UAE’s Ministry of Health and Prevention has issued a circular withdrawing a batch of a pharmaceutical product after finding a mistake on a label, officials announced on Sunday.

In a statement, the ministry said that batch No. 0093 of the 10 mg Laxocodyl suppositories – which are used for the treatment of constipation – were incorrectly marked as being for children rather than adults, which could result in them having a double dose and suffering side effects.

The medicine is manufactured by JulpharGulf Pharmaceutical Industries Manufacturers.

August 18, 2019

Amna, a 43-year-old female started experiencing poor vision in her right eye a few weeks prior to evaluation. Being a diabetic, she decided to seek medical attention and possible intervention by an expert. On visiting Emirates Hospital - Jumeirah (EHJ), an Emirates Healthcare Company and an internationally recognised 100-bed beacon of progress in the region’s healthcare system, she was referred to her Interventional Cardiologist of choice who diagnosed severe blockages in her right neck artery (right internal carotid artery), hindering the supply of oxygenated blood to the brain. Further assessments confirmed that the artery on her right side of the neck was blocked by approximately 90 percent.

In"...

August 17, 2019

Gulf Pharmaceutical Industries, one of the largest pharmaceutical manufacturers in the Middle East and Africa, has reported a 'disappointing' net loss in the second quarter of 2019.

The loss of AED96 million ($26.1 million) on sales of AED100 million in the three months from April to June come as the company, better known as Julphar, continues to be impacted by a ban on its products in Saudi Arabia.

Jerome Carle, CEO of Julphar, said: 'Our second quarter performance was disappointing primarily due to continued challenges in Saudi Arabia coupled with unfavourable"...

August 15, 2019

The Edogawa NICHE Committee today announced that the 2019-Edogawa NICHE Prize (www.edogawanicheprize.org) has been awarded to Dr. Steven A. Rosenberg, for his pioneering work in developing effective adoptive immunotherapies and genetically modified T cells which has heralded the birth of a new chapter in the fight against cancer. Dr. Rosenberg’s accomplishment has significantly contributed to the development of several immune system-based drugs and clinically"...

August 15, 2019

AHF lauded today a historic decision by the United Nations Secretary-General to appoint Winnie Byanyima as the new Executive Director of the Joint United Nations Programme on HIV/AIDS (UNAIDS). Byanyima, who is a prominent Ugandan diplomat and humanitarian, will be the first woman Executive Director to lead the agency since its launch in 1996.

Byanyima’s appointment comes in the wake of a leadership transition at UNAIDS which was precipitated by the departure of its previous Executive Director, Michel Sidibé, following an alleged cover-up of a sexual harassment investigation involving senior agency staff and reports of abuse of"...

August 14, 2019

Social media use raises children’s risk of mental health problems by up to half, a major study has found.

Almost 10,000 youths aged 13 to 16 were observed over three years in England between 2013-2015 in the study published by The Lancet Child & Adolescent Health journal.

The study suggested efforts should be made to reduce young people's exposure to harmful content online.

Very frequent use of social media may compromise teenage girls' mental health by increasing exposure"...

August 14, 2019

Concept Medical Inc. (CMI) has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for MagicTouch PTA (Percutaneous Transluminal Angioplasty), its Sirolimus drug coated balloon (DCB) catheter, for the treatment of Peripheral Artery Disease (PAD) in Below-the-Knee (BTK). Concept Medical Inc. is backed by cardiologist, philanthropist and serial entrepreneur Dr. Kiran Patel, a staunch supporter of innovative and disruptive medical devices, providing breakthrough treatments to the people of the world. Under the leadership of drug delivery pioneer Dr. Manish Doshi, the company has initiated an extensive range of worldwide clinical programs to create evidence for its innovative drug delivery devices. Concept Medical Inc has pioneered the Sirolimus drug delivery platform technology (Nanolute Technology) which has a proven commercial history in the coronary applications in more than 30,000 patients worldwide. MagicTouch PTA Sirolimus coated balloon is developed using this Nanolute Technology for use in PAD. In an ongoing clinical study (XTOSI), Associate Professor Edward CHOKE, Principal Investigator of the study and Chief of Vascular Surgery, Sengkang General Hospital, Singapore, said, “study is the world’s first pilot study to investigate the safety and efficacy of novel MagicTouch PTA Sirolimus drug coated balloon (SCB) in the treatment of below the knee arterial lesions......

August 14, 2019

Emirates Hospital - Jumeirah was recently awarded the Collaboration of Organised and Recognised Endoscopy units (CORE) certificate by the World Endoscopy Organisation (WEO). Only five hospitals in the entire region received this recognition.

Through this recognition WEO is looking at reaching out to endoscopy units worldwide to improve the quality of practice of endoscopy. The certification is awarded to endoscopy departments worldwide and recognises units performing Gastro-Intestinal endoscopy whilst adhering to the minimum criteria for endoscopy safety, covering the standards of hygiene, disinfection and the necessary training for any practice"...

August 8, 2019

Sanjeev Krishna Yoga centre in Dubai has claimed it can cure depression through yoga in just 10 days.

An advertisement for the centre on Dubai’s Sheikh Zayed Road states, “Beat depression, migraine, stress in only 10 days with no medicines. Join rhythm of life”.

Sanjeev Krishna, founder and director of Sanjeev Krishna Yoga (SKY), set up the centre in Dubai in 2003 and offers classes for individuals, families, educational institutions, universities and corporates. He said"...

August 8, 2019

Masimo (NASDAQ: MASI) announced today that in a study published in the Journal of Clinical Monitoring and Computing, researchers investigated the effects of implementing a hospital-wide fluid and blood administration protocol using two Masimo measurements: noninvasive, continuous hemoglobin (SpHb®) and pleth variability index (PVi®).1 To evaluate the impact of the implementation, they collected data on transfusions and mortality 30 and 90 days after surgery and compared the findings between"...